This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1968 Jun 17;204(12):1045-8.

Mitomycin C therapy in advanced gastrointestinal cancer

C G Moertel, R J Reitemeier, R G Hahn

PMID: 5694750

Mitomycin C therapy in advanced gastrointestinal cancer

C G Moertel et al. JAMA. 1968.

. 1968 Jun 17;204(12):1045-8.

Authors

C G Moertel, R J Reitemeier, R G Hahn

PMID: 5694750

No abstract available

PubMed Disclaimer

Similar articles

Mitomycin-C therapy in advanced gastrointestinal malignant tumours.
Vaidya MP, Prasad CN, Roy SK, Singh HN. Vaidya MP, et al. Indian J Cancer. 1974 Sep;11(3):255-61. Indian J Cancer. 1974. PMID: 4140845 No abstract available.
[Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
Fujii M, Murakami N, Matsuka Y, Ejiri T, Asano K. Fujii M, et al. Gan No Rinsho. 1983 Feb;29(2):A-8, 129-32. Gan No Rinsho. 1983. PMID: 6308301 Japanese.
Phase I-II evaluation of weekly mitomycin-C (NSC-26980) for patients with metastatic GI and breast malignancies.
Hum GJ, Bogdon DL, Bateman JR. Hum GJ, et al. Oncology. 1974;30(3):236-43. doi: 10.1159/000224961. Oncology. 1974. PMID: 4459738 No abstract available.
[Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
Nicolás JM, Villalta J, González-Clemente JM, Antúnez E, Almirall J, Bosch J, Torras A, Urbano-Márquez A. Nicolás JM, et al. Rev Clin Esp. 1990 Mar;186(4):166-70. Rev Clin Esp. 1990. PMID: 2114657 Review. Spanish.
Mitomycin C therapy in superficial bladder cancer.
Denis L, Keuppens F, Hendrickx G. Denis L, et al. Prog Clin Biol Res. 1985;185B:113-22. Prog Clin Biol Res. 1985. PMID: 3929269 Review. No abstract available.

See all similar articles

Cited by

The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.
Pan SS, Akman SA, Forrest GL, Hipsher C, Johnson R. Pan SS, et al. Cancer Chemother Pharmacol. 1992;31(1):23-31. doi: 10.1007/BF00695990. Cancer Chemother Pharmacol. 1992. PMID: 1458556
Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer.
Poplin EA, LoRusso P, Lokich JJ, Gullo JJ, Leming PD, Schulz JJ, Veach SR, McCulloch W, Baker L, Schein P. Poplin EA, et al. Cancer Chemother Pharmacol. 1994;33(5):415-9. doi: 10.1007/BF00686271. Cancer Chemother Pharmacol. 1994. PMID: 8306416 Clinical Trial.
Acute Liver Failure Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report.
Kohli P, Penumadu P, Subramaniam R. Kohli P, et al. Cureus. 2019 Jun 28;11(6):e5026. doi: 10.7759/cureus.5026. Cureus. 2019. PMID: 31497453 Free PMC article.
Modulation of mitomycin C-induced multidrug resistance in vitro.
Dorr RT, Liddil JD. Dorr RT, et al. Cancer Chemother Pharmacol. 1991;27(4):290-4. doi: 10.1007/BF00685114. Cancer Chemother Pharmacol. 1991. PMID: 1671830
The role of antitumor antibiotics in current oncologic practice.
Davis HL Jr, von Hoff DD, Henney JE, Rozencweig M. Davis HL Jr, et al. Cancer Chemother Pharmacol. 1978;1(2):83-90. doi: 10.1007/BF00254041. Cancer Chemother Pharmacol. 1978. PMID: 219963 Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems